About Bali Muralidhar
Bali Muralidhar is a director at Allotera Therapeutics.
Bali Muralidhar reports to the SEC as a director of 3 public companies: Spruce Biosciences (SPRB), OnKure Therapeutics (OKUR) and Exicure (XCUR).
Bali Muralidhar first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Bali Muralidhar in the role, so the role may have started earlier or lasted longer.
Allotera Therapeutics, Inc.
Director
2021 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
SI
Spruce Biosciences, Inc.
Director
2020 – 2025 · Public company (SPRB)
OI
OnKure Therapeutics, Inc.
Director
2021 – 2023 · Public company (OKUR)
EI
Exicure, Inc.
Director
2019 – 2022 · Public company (XCUR)
Key Colleagues at Startups
The people Bali Muralidhar works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
NM
Natalie Mount
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D